Wang Qiuping, press spokesman of the General Administration of Market Regulation and director of the Press and Publicity Department, said at a press conference today that the next step is to continue to step up anti-monopoly enforcement in the pharmaceutical field, maintain a “sharp sword” high-pressure situation for any illegal act that threatens the safety of people and increases people's livelihood costs, protect people's “life-saving drugs” and “safe prices”, and never allow enterprises to “operate with diseases” damage public health, and never allow the market to “blindfold and seek profit” to erode public interests.

Wang Qiuping, press spokesman of the General Administration of Market Regulation and director of the Press and Publicity Department, said at a press conference today that the next step is to continue to step up anti-monopoly enforcement in the pharmaceutical field, maintain a “sharp sword” high-pressure situation for any illegal act that threatens the safety of people and increases people's livelihood costs, protect people's “life-saving drugs” and “safe prices”, and never allow enterprises to “operate with diseases” damage public health, and never allow the market to “blindfold and seek profit” from eroding the public interest.